Rithm's Strong FY25 Performance Reinforces Diversification Thesis Amid Persistent Market Discount

What happened

Rithm Capital reported robust FY25 financials, with a 19% EAD return on equity and normalized EPS of $0.74 exceeding consensus by over 23%. This performance underscores the company's ongoing transition from a mortgage REIT to a diversified global alternative asset manager, as highlighted in recent analyses. However, the stock continues to trade at a substantial discount to book value, around 0.75-0.76x P/B, reflecting persistent market valuation akin to traditional mortgage REITs. The DeepValue report maintains a BUY stance, citing the discount's rerating potential and the platform's resilience from diversified earnings, including MSRs/credit and fee income from Sculptor. Despite the positive earnings, the lingering discount suggests underlying market concerns about macro risks, such as rate volatility and funding costs, which could pressure book value and dividend capacity.

Implication

The strong FY25 earnings validate Rithm's diversification strategy, reducing reliance on pure mortgage spread income and enhancing earnings stability. Trading below book value offers upside if the discount narrows, especially with growth in fee-based AUM and stabilized funding conditions. However, the persistent discount indicates market skepticism about the sustainability of earnings amid higher-for-longer rates and intense competition. Key risks include potential book value erosion from credit marks or funding shocks, which could impact dividend coverage and investor returns. Investors should monitor quarterly BVPS, fee AUM flows, and dividend declarations to gauge the thesis's validity and adjust positions accordingly.

Thesis delta

The article's positive FY25 results reinforce the DeepValue BUY thesis by demonstrating successful diversification and earnings strength. However, the unchanged discount indicates that market perception and risk factors remain similar, emphasizing the need for vigilance on macro conditions and fee growth to validate the rerating potential.